Colorectal Neoplasms: all 5,738 studies
Page 30 of 58. Open to participants first (1,483), then studies with results posted, then the rest; newest registration first within each.
- Efficacy of Web-based Self-management Support Intervention on Health Outcomes in Patients With Colorectal CancerStatus unknownNCT05045976Not applicable
- An Endoscopic Barbed-clips Suturing for Colorectal ESDStatus unknownNCT05045911Not applicable
- SI-B001 as a Single Agent or in Combination With Chemotherapy in the Treatment of Digestive System MalignanciesTerminatedNCT05039944Phase 2
- A Study of ERAS-007 in Patients With Advanced Gastrointestinal MalignanciesCompletedNCT05039177Phase 1/2
- Modified MAC Diet and Gut Microbiota in CRC PatientsStatus unknownNCT05039060Not applicable
- DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual DiseaseCompletedNCT05036109Not applicable
- Anlotinib Combined With mXELIRI as Second-line Treatment of Advanced Colorectal CancerStatus unknownNCT05035914Phase 1/2
- PD-1 Inhibitor Combined With Bevacizumab and FOLFIRI Regimen in the Second-line Treatment of Advanced Colorectal CancerStatus unknownNCT05035381Phase 2
- Temozolomide and Irinotecan in Patients With MGMT Silenced Colorectal Cancer After Adjuvant ChemotherapyStatus unknownNCT05031975Phase 2
- An Additional Analysis of Data From the PARADIGM Exploratory Study (NCT02394834) in Patients With Advanced/Recurrent Colorectal CancerActive, not recruitingNCT05030493
- Integrative Nutrition Care Plan for the Patient With Liver and Colorectal CancerCompletedNCT05030090Not applicable
- Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV BevacizumabActive, not recruitingNCT05029882Phase 1
- Ask Questions (ASQ):Implementation of a Communication InterventionCompletedNCT05025748Not applicable
- A Phase II Study on Dose Optimization of Fruquintinib in Elderly mCRC Patients Refractory to Standard Treatment（DOFEMCRC）CompletedNCT05025631Phase 2
- Real-World Effectiveness of Regorafenib in the Treatment of Patients With Metastatic Colorectal CancerStatus unknownNCT05023720
- Three Birds With One StoneCompletedNCT05022511Not applicable
- Incorporating ePrognosis for the Encouragement of Smarter Screening for Breast and Colorectal Cancer in Older AdultsCompletedNCT05021172Not applicable
- Tolerability and Safety of Vemurafenib, Cetuximab Combined With Camrelizumab for BRAF V600E-mutated /MSS Metastatic Colorectal CancerStatus unknownNCT05019534Phase 1
- FOLFOXIRI for Neoadjuvant Treatment of High-risk Locally Advanced Colorectal CancerStatus unknownNCT05018182Phase 2
- Default Genetics Referrals for Young-Onset Colorectal CancerCompletedNCT05018156Not applicable
- Fruquintinib Plus Capecitabine as Maintenance Treatment of RAS / BRAF Wild-type Metastatic Colorectal CancerStatus unknownNCT05016869Phase 1/2
- A Study of JNJ-64251330 in Participants With Familial Adenomatous PolyposisCompletedNCT05014360Phase 1
- ENDO-AID Assisted Tandem Colonoscopy RCTCompletedNCT05013125Not applicable
- Reminder Modality for CRC ScreeningCompletedNCT05012007Not applicable
- Surveillance Modified by Artificial Intelligence in Endoscopy (SMARTIE)CompletedNCT05006092Not applicable
- Laparoscopic Approach for Emergency Colon ResectionActive, not recruitingNCT05005117Not applicable
- Fruquintinib Combined With TAS-102 in the Treatment of Patients With Advanced Metastatic CRCStatus unknownNCT05004831Phase 2
- Fruquintinib Combined With mFOLFOX6/FOLFIRI in First-line Treatment for Metastatic Colorectal CancerCompletedNCT05004441Phase 2
- Text-based Colorectal Cancer Prevention PilotCompletedNCT05004376Not applicable
- Effect of Implementation of Enhanced Recovery After Surgery on 3-year Survival After Colorectal Surgery for CancerCompletedNCT05002855
- Feasibility of 2 Interventions to Reduce Fatigue in Patients With Chemotherapy for Metastatic Colorectal CancerTerminatedNCT04999306Not applicable
- Carbohydrate Antigen 19-9 in Colorectal CancerStatus unknownNCT04999072
- Organoids-on-a-chip for Colorectal Cancer and in Vitro Screening of Chemotherapeutic DrugsStatus unknownNCT04996355
- A Research Study to Collect Patient Reported Outcomes Using Electronic SurveysTerminatedNCT04990895Not applicable
- Study of INCA 0186 in Subjects With Advanced Solid TumorsTerminatedNCT04989387Phase 1
- Toripalimab Plus Bevacizumab and Chemotherapy as Neoadjuvant Therapy in Advanced MSI-H or dMMR Colorectal CancerStatus unknownNCT04988191Phase 1/2
- The Efficacy of HLX208 (BRAF V600E Inhibitor) With Cetuximab for Metastatic Colorectal Cancer (mCRC) With BRAF V600E Mutation After First-line TreatmentActive, not recruitingNCT04984369Phase 2
- "The Impact of Immunonutrition on Gut Microbiota-related Aspects in Colorectal Cancer and Gastric Cancer Patients"Status unknownNCT04980950Not applicable
- Evaluation of a New Blood-based Test to Detect Colorectal Cancer and Its PrecursorsCompletedNCT04980443Not applicable
- CARES-HCV: Promoting Screening Uptake Among Diverse Baby BoomersCompletedNCT04980157
- Patogenic Mutation in 5 GenesCompletedNCT04976439
- Anlotinib Plus Penpulimab (AK105) for Chemo-refractory Metastatic Colorectal Cancer:ALTER-C003Status unknownNCT04970914Phase 2
- Late Organ Specific Adverse Effects hiPec or pElvic eXenterationStatus unknownNCT04970316
- Polyprev: Study to Compare Fecal Immunochemical Test With Endoscopic Surveillance After Advanced Adenoma Resection in Fecal Immunochemical Test Colorectal Cancer Screening Programs.Active, not recruitingNCT04967183Not applicable
- A Study of Trifluridine/ Tipiracil in Chemorefractory mCRC in GreeceCompletedNCT04965870
- Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal CancerActive, not recruitingNCT04963283Phase 2
- Multicenter Study on the Pathogenic Germline Gene Variants of Colorectal Polyposis in ChinaStatus unknownNCT04961125
- Multi-center Application of Quantitative FIT Technology in Colorectal Cancer ScreeningStatus unknownNCT04959617
- Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)Active, not recruitingNCT04956640Phase 1/2
- Study of NIS793 and Other Novel Investigational Combinations With SOC Anti-cancer Therapy for the 2L Treatment of mCRCTerminatedNCT04952753Phase 2
- Post-Trial Access for Guselkumab in Participants With Familial Adenomatous PolyposisNo longer availableNCT04948398
- The Combination of Fruquintinib, Tislelizumab and Stereotactic Ablative Radiotherapy in Metastatic Colorectal Cancer(RIFLE)Status unknownNCT04948034Phase 2
- Myeloid-derived Suppressor Cells in Colorectal CancerCompletedNCT04943419
- ColoRectal Cancer Screening for Southern California Community Health CentersCompletedNCT04941300Phase 3
- Neoadjuvant Safety of Sintilimab + XELOX + Bevacizumab in PMMR/MSS CRLM PatientsActive, not recruitingNCT04940546Phase 1/2
- Outreach and Choice in Colorectal Cancer ScreeningStatus unknownNCT04940442Not applicable
- Quality of Life and Survival of Patients With Colorectal Cancer 5 Years After Surgery - Follow-up of the RCT DIQOLCompletedNCT04930016
- Surufatinib Combine With Immunotherapy and Chemotherapy for Second-line Treatment in Advanced Colorectal CancerStatus unknownNCT04929652Phase 1/2
- Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) and Metastatic Colorectal Cancer (mCRC)CompletedNCT04926376Not applicable
- Exercise Preconditioning with Cancer SurgeriesTerminatedNCT04923672Not applicable
- Veteran Primers for CRC ScreeningCompletedNCT04923646Not applicable
- Interest of Artificial Intelligence in Cancer Screening ColonoscopyCompletedNCT04921488Not applicable
- Relapse Markers for Colorectal CancerCompletedNCT04920955
- RE-SEARCH Study: A Study to Learn How and in Which Amount Regorafenib is Given in Usual Practice to Patients in Spain: a Study Looking Back at Cases That Have Already Happened When the Study Begins.CompletedNCT04920422
- Computer-aided Detection During Screening Colonoscopy (Experts)Status unknownNCT04915833Not applicable
- Establishment and Clinical Validation of New Technologies for Accurate Screening of Colorectal Cancer Based on Multi-omicsStatus unknownNCT04913233
- Neoadjuvant Chemoradiotherapy Plus Tislelizumab Followed by TME for LARC.Status unknownNCT04911517Phase 2
- Endoscopic Surveillance in Serrated Polyposis Syndrome and Low-risk of Advanced NeoplasiaCompletedNCT04906343Not applicable
- Efficacy of Mosapride on Recovery of Intestinal Motility After Elective Colorectal Cancer SurgeryStatus unknownNCT04905147Not applicable
- Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid TumorsCompletedNCT04902872Phase 1/2
- Feasibility Study of a 4 Stage Bowel Obstruction Cancer DietCompletedNCT04898842Not applicable
- HAI-Floxuridine, or Liver-Tx, Combined With 2nd Line Chemotherapy Versus 2nd Line Chemotherapy Alone for Patients With Colorectal Liver Metastases and Heavy Tumour Burden.TerminatedNCT04898504Phase 2
- mFOLFOX6+Bevacizumab+PD-1 Monoclonal Antibody in Local Advanced MSS CRCCompletedNCT04895137Phase 2
- Study of ESG401 in Adults With Solid TumorsCompletedNCT04892342Phase 1/2
- The Impact of Transanal Decompression Tube Placement After Colorectal Anastomosis: A Randomized TrialStatus unknownNCT04890015Not applicable
- A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various CancerWithdrawnNCT04889495
- Factors Affecting the Time to Start Postoperative Chemotherapy in Colorectal CancerCompletedNCT04885283
- Evaluation of a Cosmetic Product to Preserve Skin Conditions When Using Anti-EGFR Cancer TherapiesStatus unknownNCT04878692Not applicable
- Optimizing Physical Function Before Cancer Surgery in Older People at RiskStatus unknownNCT04878185Not applicable
- Effectiveness of an Integrated Colorectal Cancer Screening in Saudi Arabia: A Pragmatic Randomized TrialCompletedNCT04875793Not applicable
- TACE Plus Axitinib and Hydroxychlorquine for Liver-Dominant Metastatic Colorectal Cancer (CRC)TerminatedNCT04873895Phase 1
- Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic CancerWithdrawnNCT04870034Early Phase 1
- Gut Microbiome Modification Through Dietary Intervention in Patients With Colorectal Cancer: Response to SurgeryStatus unknownNCT04869956Not applicable
- Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in CombinationTerminatedNCT04868877Phase 1/2
- Study of Cabozantinib Plus TAS102 in mCRC as Salvage TherapyCompletedNCT04868773Phase 1
- Fruquitinib Combined With Camrelizumab in Non MSI-H/dMMR Refractory Colorectal CancerStatus unknownNCT04866862Phase 2
- A Phase II Study of Fruquintinib Combined With Capecitabine as First-line Treatment for Advanced Metastatic Colorectal Cancer Unsuitable for Intravenous ChemotherapyStatus unknownNCT04866108Phase 2
- Molecular Profiling of Colorectal CancerStatus unknownNCT04863768
- Computerized Feedback in ColonoscopyStatus unknownNCT04862793Not applicable
- A Clinical Studyf of SHR-1701 or Placebo in Combination With BP102 and XELOX in the First-line Treatment of mCRCTerminatedNCT04856787Phase 2/3
- Ultra-sensitivity Quantitative Fecal Immunochemical Test in Detecting Colorectal Advanced Adenoma and Colorectal CancerStatus unknownNCT04856423
- A Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal CancerActive, not recruitingNCT04854668Phase 3
- Implementing Fit Kit Colorectal Cancer (CRC) Screening in High Risk PopulationsCompletedNCT04848051Not applicable
- Ex Vivo Intraarterial Methylene Blue Injection Improve Nodal Staging Accuracy in Colorectal CancerCompletedNCT04842968Not applicable
- EXtended CriteriA Treatment for LIver Metastases and Heavy Tumour BURdenSuspendedNCT04840186Phase 2
- Regorafenib Treatment Patterns and Survival Outcomes in Advanced Colorectal Cancer: A Real-world StudyStatus unknownNCT04835324
- Comparison of A140 and Erbitux Combined With mfolfox6 to Evaluate Efficacy and Safety of First-line Treatment for Ras Wild-type mCRCCompletedNCT04835142Phase 3
- PD-1 Antibody Following Preoperative Chemoradiotherapy for Locally Advanced pMMR/MSS Rectal CancerActive, not recruitingNCT04833387Phase 2
- c-CetuIRI Versus Ersecond-line Irinotecan s-IRI-CetuIRIStatus unknownNCT04833036Phase 2
- Medical and Psychosocial Issues in Adolescents and Young Adults With Colorectal CancerActive, not recruitingNCT04832763Not applicable